1. Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States. (15th June 2019) Authors: Richardson, Jason S; Parrera, Geraldine S; Astacio, Hugo; Sahota, Harpreet; Anderson, Deborah M; Hall, Christine; Babinchak, Tim Journal: Clinical infectious diseases Issue: Volume 70:Number 9(2020) Page Start: 1950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial. Issue 9 (September 2022) Authors: Bennett, Sean R; McCarty, James M; Ramanathan, Roshan; Mendy, Jason; Richardson, Jason S; Smith, Jonathan; Alexander, Jeff; Ledgerwood, Julie E; de Lame, Paul-André; Royalty Tredo, Sarah; Warfield, Kelly L; Bedell, Lisa Journal: Lancet infectious diseases Issue: Volume 22:Issue 9(2022) Page Start: 1343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗